Kevin Tang

Insider Reports History

Entity
Individual
Location
4747 Executive Drive, Suite 210, San Diego, CA
Signature
Kevin Tang
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Kevin Tang:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Aurinia Pharmaceuticals Inc. Director Common Shares 7.23M $38.4M $5.31 Sep 12, 2024 By LP
Odonate Therapeutics, Inc. Chief Executive Officer, Director, 10%+ Owner Common Stock 12.8M $20M $1.57 Nov 19, 2021 By LP
Singular Genomics Systems, Inc. 10%+ Owner Common Stock 372K $6.4M $17.21 Sep 18, 2024 By LP
Jounce Therapeutics, Inc. Director, 10%+ Owner Common Stock 10K $18.5K $1.85 May 3, 2023 By LP
Rain Oncology Inc. 10%+ Owner Common Stock 0 $0 $1.21 Jan 26, 2024 By LP
TCR2 THERAPEUTICS INC. 10%+ Owner Common Stock 0 $0 $1.72 Jun 1, 2023 By LP
Aptevo Therapeutics Inc. Exit Filing Common Stock 0 Nov 23, 2021 By LP
LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Common Stock 0 $6.23 Aug 22, 2022 BY LP
LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Series C-1(2) Convertible Preferred Stock 0 Aug 22, 2022 BY LP
LA JOLLA PHARMACEUTICAL CO Director, 10%+ Owner Stock Option (Right to Buy) 0 Aug 22, 2022 Direct

Insider Reports Filed by Kevin Tang

Symbol Company Period Transactions Value $ Form Type Date Filed Role
OMIC Singular Genomics Systems, Inc. Sep 16, 2024 3 $1.81M 4 Sep 18, 2024 10%+ Owner
OMIC Singular Genomics Systems, Inc. Sep 16, 2024 0 $0 3 Sep 18, 2024 10%+ Owner
AUPH Aurinia Pharmaceuticals Inc. Sep 12, 2024 0 $0 3 Sep 23, 2024 Director
RAIN Rain Oncology Inc. Jan 26, 2024 1 $0 4 Feb 2, 2024 10%+ Owner
RAIN Rain Oncology Inc. Dec 14, 2023 3 -$209K 4 Dec 18, 2023 10%+ Owner
RAIN Rain Oncology Inc. Oct 11, 2023 5 $279K 4 Oct 13, 2023 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. Jun 1, 2023 1 $0 4 Feb 14, 2024 10%+ Owner
RAIN Rain Oncology Inc. May 30, 2023 9 $1.16M 4 Jun 1, 2023 10%+ Owner
RAIN Rain Oncology Inc. May 30, 2023 0 $0 3 Jun 1, 2023 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. May 25, 2023 1 $86K 4 May 30, 2023 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. May 11, 2023 2 $87.6K 4 May 15, 2023 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. May 8, 2023 3 $164K 4 May 10, 2023 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. May 3, 2023 4 $548K 4 May 5, 2023 10%+ Owner
TCRR TCR2 THERAPEUTICS INC. May 3, 2023 0 $0 3 May 5, 2023 10%+ Owner
JNCE Jounce Therapeutics, Inc. May 3, 2023 2 $87.6M 4 May 5, 2023 Director, 10%+ Owner
JNCE Jounce Therapeutics, Inc. Mar 13, 2023 2 $86K 4 Mar 14, 2023 10%+ Owner
JNCE Jounce Therapeutics, Inc. Mar 13, 2023 0 $0 3 Mar 14, 2023 10%+ Owner
LJPC LA JOLLA PHARMACEUTICAL CO Aug 22, 2022 11 -$59.9M 4 Aug 24, 2022 Director, 10%+ Owner
LJPC LA JOLLA PHARMACEUTICAL CO Aug 22, 2022 2 -$59.9M 4 Aug 24, 2022 Director, 10%+ Owner
LJPC LA JOLLA PHARMACEUTICAL CO Jan 12, 2022 1 $0 4 Jan 14, 2022 Director, 10%+ Owner
LJPC LA JOLLA PHARMACEUTICAL CO Nov 29, 2021 5 -$1.73M 4 Dec 1, 2021 Director, 10%+ Owner
APVO Aptevo Therapeutics Inc. Nov 23, 2021 7 -$10.4M 4 Nov 26, 2021 Exit Filing
APVO Aptevo Therapeutics Inc. Nov 18, 2021 10 -$6.5M 4 Nov 22, 2021 10%+ Owner
ODT Odonate Therapeutics, Inc. Nov 17, 2021 8 -$5.73M 4 Nov 19, 2021 Chief Executive Officer, Director, 10%+ Owner
LJPC LA JOLLA PHARMACEUTICAL CO May 27, 2021 4 $1.1M 4 Jun 1, 2021 Director, 10%+ Owner
LJPC LA JOLLA PHARMACEUTICAL CO May 24, 2021 4 $1.58M 4 May 26, 2021 Director, 10%+ Owner